InvestorsHub Logo
Followers 70
Posts 1351
Boards Moderated 0
Alias Born 08/12/2014

Re: None

Tuesday, 12/18/2018 12:25:03 PM

Tuesday, December 18, 2018 12:25:03 PM

Post# of 732703
Linda ought be given maximal flexibiliy possible in terms of when exactly the trial will be locked and topline data be published.

The reason is quite simple: the only thing wolfpack has not been paniic yet is they know there is no imminent danger of topline data or its equivelent like substantial interests from long hedgfunds, or substantial lisence deals, buyout, or the like, as there now will be no concern whatever of the demise of the company for at least one or two years due to the recent secured funding from the sale of property.

Unless there is a mole in FDA who is feeding the wolfpack of inside information, in my opinion the only hope for the wolfpack to not be panic is a clear guideline from Linda.

If you are longs who do not depend on flipping shares to average down and have hold the opinion that no matter what the trial will be a success, and the the treatment will be approved, I don't think it will be hard to not give her all the resorts she can have.

Because of wolfpack, we have been suffering too much; the patients have been suffering too much; and the general investment community have been deprived of true and correct information about this company and its disruptive and promising immunotherapeutic platform. So it's time to give Linda the trust and means so as to uproot the wolfpack once for all, because it is the best interest of all stackholders and patients.

I believe we are near the truth\news, and I have no problem to wait a few more months if we have to.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News